The Digestive Diseases Research Core Center brings together a multidisciplinary group of independently funded principal investigators and professional supporting personnel from the Departments of Medicine, Pathology, Diagnostic Radiology, Laboratory Medicine, Physiology, Human Genetics and Cell Biology at Yale School of Medicine, in order to further the study of liver structure, function and disease at this institution. The Center focuses on 5 major themes: (1) Mechanisms of hepatic transport and bile secretion; (2) Hepatic metabolic functions including bilirubin metabolism, effects of ethanol, and genetic aspects of mitochondrial enzyme function; (3) Hepatic fibrogenesis; (4) Splanchnic hemodynamics; and (5) Human liver transplantation. The research activities of the Center are broad, and range from fundamental studies of the biology of the hepatocyte to the immediate relevancy of the evaluation of the human liver transplant. The principle goals of the Center have been to: (1) stimulate multidisciplinary interactions; (2) efficiently organize time consuming or costly techniques and procedures in Core Facilities for multiple use; (3) stimulate basic scientists to become involved in one or more of the Center's areas of research interest; (4) capitalize on important new research opportunities through pilot feasibility projects; and (5) create an institutional environment that will greatly amplify progress in answering problems in this important area of Digestive Disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034989-04
Application #
3102081
Study Section
(SRC)
Project Start
1984-09-30
Project End
1989-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Ouyang, Xinshou; Han, Sheng-Na; Zhang, Ji-Yuan et al. (2018) Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1? Transactivation in Steatohepatitis. Cell Metab 27:339-350.e3
Chen, Yonglin; Ouyang, Xinshou; Hoque, Rafaz et al. (2018) ?-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway. J Hepatol 69:687-696
Manfredo Vieira, S; Hiltensperger, M; Kumar, V et al. (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359:1156-1161
Lawan, Ahmed; Min, Kisuk; Zhang, Lei et al. (2018) Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance. Diabetes 67:624-635
Franca, Andressa; Filho, Antonio Carlos Melo Lima; Guerra, Mateus T et al. (2018) Effects of endotoxin on type 3 inositol 1,4,5-trisphosphate receptor in human cholangiocytes. Hepatology :
Liu, Chune; Yang, Zhihong; Wu, Jianguo et al. (2018) Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis. Hepatology 67:1768-1783
Brivio, Simone; Cadamuro, Massimiliano; Fabris, Luca et al. (2018) Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expr 18:31-50
Cox, Carly S; McKay, Sharen E; Holmbeck, Marissa A et al. (2018) Mitohormesis in Mice via Sustained Basal Activation of Mitochondrial and Antioxidant Signaling. Cell Metab 28:776-786.e5
Madiraju, Anila K; Qiu, Yang; Perry, Rachel J et al. (2018) Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med 24:1384-1394
Schmitz, Corinna; Noels, Heidi; El Bounkari, Omar et al. (2018) Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. FASEB J 32:4428-4443

Showing the most recent 10 out of 763 publications